WeVote
Log In

Bill

Bill

HB 872

Health Care - As introduced, enacts the "Tennessee Medical Cannabis Act," which establishes a medical cannabis program to be administered by the Tennessee medical cannabis program commission. - Amends TCA Title 4; Title 38, Chapter 3; Title 39, Chapter 17; Title 43; Title 50; Title 53; Title 63; Title 67 and Title 68.

114th Regular Session (2025-2026) Introduced by Iris Rudder

Tennessee bill creates regulated medical cannabis program administered by state commission, legalizing cannabis for qualifying patients while establishing licensing, cultivation, and distribution regulations.

Assigned to s/c Health Subcommittee
#healthcare
0
WeVote Research Nonpartisan
Bill Summary · HB 872

Legislative bill overview

HB 872 proposes establishing Tennessee's first regulated medical cannabis program, creating a state commission to administer licensing, cultivation, distribution, and patient access. The bill requires amendments across eight major Tennessee code titles, indicating comprehensive regulatory framework changes affecting health, criminal justice, taxation, and licensing systems.

Why is this important

This represents a significant shift in Tennessee drug policy, potentially providing legal access to cannabis for patients with qualifying medical conditions while generating state revenue and tax income. The program would create new industry jobs, establish patient protections, and require law enforcement and healthcare systems to adapt to new regulations.

Potential points of contention

  • Criminal justice concerns: Existing cannabis convictions and how they're addressed; potential conflicts with federal law since cannabis remains federally illegal
  • Program specifics unclear: The bill synopsis doesn't detail which medical conditions qualify, licensing costs, cultivation limits, or testing standards—critical details that affect access and quality
  • Industry regulation scope: Questions about who controls production/distribution (state monopoly vs. private licenses), pricing controls, and how to prevent illegal market competition
  • Implementation costs: Establishing the commission and regulatory infrastructure requires state funding; unclear if patient fees and business licensing generate sufficient revenue

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.